OakChart

Merck & Co Inc

MRKHealthcare·Drug Manufacturers - General·USA·Mega·NYSE·Nov 11 • 1:34 PM ET

146.56-1.49 (-1.01%)
2026-11-11 19:34 CET
Market cap
364,980.26 USD m
Revenue, TTM
67,227.00 USD m
Net income, TTM
2,453.00 USD m
Free cash flow, TTM
14,746.00 USD m
EPS diluted, TTM
0.98
P/E
149.67
Compare

Price

MRK against its 20, 50 and 200-day averages
2050200beatmiss
100.00120.00140.00160.0016.4M32.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MRKclose 146.5620-day 146.2650-day 146.31200-day 128.24146.5652w high

6.6% under the 52-week high of 156.92 on 25 Aug 2026. 52-week low 87.26 on 11 Nov 2025. Last 15 sessions, 10.6% high to low

Profile

MRK
52-week range, 85% of the way up
87.26156.92

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

IndexDJIA, S&P 500, RUI
Employees75000
IPOJun 15, 1946
Beta0.12
ATR, 14d4.40
Rel volume0.36
Short float1.08%
Insider own0.10%
Inst own82.93%

Snapshot

6 groups

Valuation

IndexDJIA, S&P 500, RUI
Market Cap361.31B
Enterprise Value405.38B
Income2.45B
Sales67.23B
Book/sh18.20
Cash/sh3.96
Dividend Est.3.40 (2.32%)
Dividend TTM3.40 (2.32%)
Dividend Ex-DateSep 15, 2026
Dividend Gr. 3/5Y5.42% 5.75%
Payout45.05%
Employees75000
IPOJun 15, 1946

Ratios

P/E149.67
Forward P/E16.44
PEG4.89
P/S5.37
P/B8.05
P/C37.05
P/FCF24.50
EV/EBITDA20.73
EV/Sales6.03
Quick Ratio1.14
Current Ratio1.35
Debt/Eq1.20
LT Debt/Eq1.11
Option/ShortYes / Yes

Earnings

EPS (ttm)0.98
EPS next Y8.92
EPS next Q1.76
EPS this Y-69.08%
EPS next Y221.16%
EPS next 5Y3.36%
EPS past 3/5Y8.43% 21.23%
Sales past 3/5Y3.55% 9.34%
EPS Y/Y TTM-86.88%
Sales Y/Y TTM5.21%
EPS Q/Q-11.74%
Sales Q/Q5.47%
EarningsOct 29 BMO
EPS/Sales Surpr.19.40% 4.35%

Ownership

Insider Own0.10%
Insider Trans-8.47%
Inst Own82.93%
Inst Trans0.16%
ROA1.87%
ROE5.07%
ROIC2.59%
Gross Margin71.41%
Oper. Margin18.42%
Profit Margin3.65%
SMA200.21%
SMA500.17%
SMA20014.28%
Trades-

Technical

Shs Outstand2.47B
Shs Float2.46B
Short Float1.08%
Short Ratio2.58
Short Interest26.60M
52W High156.92 -6.60%
52W Low87.26 67.96%
Volatility2.99% 3.08%
ATR (14)4.40
RSI (14)50.57
Beta0.12
Rel Volume0.36
Avg Volume10.32M
Volume2,367,603

Performance

Perf Week-2.53%
Perf Month3.23%
Perf Quarter8.12%
Perf Half Y29.18%
Perf YTD39.24%
Perf Year61.14%
Perf 3Y44.55%
Perf 5Y74.43%
Perf 10Y140.35%
Recom1.77
Target Price162.96
Prev Close148.05
Price146.56
Change %-1.01%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 03, 2026DowngradeDDZ BankBuy → Hold$153+4.4%
Aug 20, 2026UpgradeMMorgan StanleyEqual-Weight → Overweight$179+22.1%
Aug 20, 2026DowngradeRRBC Capital MktsOutperform → Sector Perform$150+2.3%
Aug 12, 2026UpgradeDDaiwa SecuritiesNeutral → Outperform$143-2.4%
May 06, 2026ResumedCCitigroupNeutral$125-14.7%
Feb 25, 2026InitiatedRRBC Capital MktsOutperform$142-3.1%
Feb 20, 2026InitiatedBBarclaysOverweight$140-4.5%
Feb 13, 2026UpgradeDDeutsche BankHold → Buy$150+2.3%
Jan 08, 2026UpgradeWWolfe ResearchPeer Perform → Outperform$135-7.9%
Dec 18, 2025UpgradeBBMO Capital MarketsMarket Perform → Outperform$130-11.3%

Peers

Mkt cap
TickerCompanyMkt cap
AZNAstrazeneca plc286.70B
BMYBristol-Myers Squibb Co127.13B
PFEPfizer Inc166.64B
GSKGSK Plc ADR100.83B
JNJJohnson & Johnson670.44B
NVSNovartis AG ADR292.46B
ABBVAbbvie Inc517.55B
LLYLilly(Eli) & Co1344.27B
SNYSanofi ADR114.62B
AMGNAMGEN Inc251.04B

Insider trading

latest 14 of 65
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
DAVID M WILLIAMSOfficerNov 02 '26Proposed Sale149.1421,3593,185,464Nov 02 04:14 PM
Guindo ChirfiEVP, Access, Policy & CommsAug 13 '26Sale135.0010,0001,350,00036,613Aug 13 05:02 PM
CHIRFI GUINDOOfficerAug 13 '26Proposed Sale135.0010,0001,350,000Aug 13 04:15 PM
Zachary JenniferEVP, General CounselAug 12 '26Option Exercise109.7854,9276,029,637125,824Aug 13 04:11 PM
Zachary JenniferEVP, General CounselAug 12 '26Sale133.4680,31510,718,49545,509Aug 13 04:11 PM
RICHARD ROBERT DELUCA JROfficerAug 12 '26Proposed Sale131.6311,6991,539,992Aug 12 04:23 PM
JENNIFER L ZACHARYOfficerAug 12 '26Proposed Sale133.4680,31510,718,495Aug 12 04:19 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 10 '26Sale130.4320,7842,710,951134,703Aug 12 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 11 '26Sale131.7612,8371,691,426121,866Aug 12 04:10 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 12 '26Sale131.6311,6991,539,992110,167Aug 12 04:10 PM
RICHARD ROBERT DELUCA JROfficerAug 11 '26Proposed Sale131.7612,8371,691,426Aug 11 04:14 PM
RICHARD ROBERT DELUCA JROfficerAug 10 '26Proposed Sale130.4320,7842,710,951Aug 10 04:43 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 06 '26Sale130.386,050788,773155,487Aug 10 04:28 PM
Maraldo David R.EVP & Pres. MMDAug 05 '26Option Exercise82.2518,7061,538,49527,921Aug 07 04:21 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
IVViShares Core S&P 500 ETFAUM: 871.38B
SCHDSchwab US Dividend Equity ETFAUM: 122.69B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
VTVVanguard Morningstar Value ETFAUM: 196.23B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
VIGVanguard Dividend Appreciation FTFAUM: 117.07B
VYMVanguard High Dividend Yield Indx ETFAUM: 83.15B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-292.4902.0852.04018,08517,33120
2026Q22026-08-04-0.130-0.271-0.54116,60716,36918
2026Q12026-04-30-1.280-1.474-1.71516,28615,84620
2025Q42026-02-032.0402.0111.19116,40016,19918
2025Q32025-10-302.5802.3622.31617,27616,97817
2025Q22025-07-292.1302.0331.76215,80615,86514
2025Q12025-04-242.2202.1332.00715,52915,33915
2024Q42025-02-041.7201.6091.47515,62415,48311
2024Q32024-10-311.5701.4841.24216,65716,47413
2024Q22024-07-302.2802.1682.14416,11215,87015
2024Q12024-04-252.0701.8861.87215,77515,20518
2023Q42024-02-010.030-0.109-0.48414,63014,48919
2023Q32023-10-262.1301.9531.86415,96215,29616
2023Q22023-08-01-2.060-2.181-2.35315,03514,44218
2023Q12023-04-271.4001.3211.10614,48713,79319
2022Q42023-02-021.6201.5351.18413,83013,65819

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY4.9494.9273.81546,84046,904
2020FY5.6645.7202.78147,99448,188
2021FY6.0205.7925.14148,70448,519
2022FY7.4807.3945.71259,28359,124
2023FY1.5101.3770.14360,11559,971
2024FY7.6507.5286.73664,16863,985
2025FY8.9808.9357.28065,01164,850
2026FY-2.776--67,245
2027FY-8.916--69,420
2028FY-9.917--73,582
2029FY-9.884--74,233
2030FY-9.819--74,850

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-091601616,29315,91816,760
2026Q4S2026-11-061601616,29315,91816,760
2026Q4S2026-11-021601616,29315,91816,760
2026Q4S2026-10-301601516,31915,91816,760
2026Q4S2026-10-291601316,41615,91816,899
2026Q4S2026-10-27162516,79116,55217,202
2026Q4S2026-10-26162516,79316,55217,202
2026Q4S2026-10-23162516,79316,55217,202
2026Q4S2026-10-21162516,79316,55217,202
2026Q4S2026-10-20162516,78616,45317,202
2026Q4S2026-10-18162516,79516,45317,202
2026Q4S2026-10-15165816,79516,45317,202
2026Q4S2026-10-12166816,80316,45317,202
2026Q4S2026-10-09165816,78516,33417,202

Estimate history

EPS, annual0.872.323.8152.7815.1415.7120.1436.7367.2810.9792
Period201720182019202020212022202320242025TTM
EPS, quarterly1.2421.4752.0071.7622.3161.191-1.715-0.5412.044
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual39981424464658641537489075847359871639736492667227
Period201720182019202020212022202320242025TTM
Sales, quarterly167151529315619158001718316324162001658018123
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual2696.6122592.562539.0162530.2262527.6042537.8342531.6332527.6372474.6272466.774
Period201720182019202020212022202320242025MRQ
Shares, quarterly2532.032527.6372516.0822503.142487.3492474.6272469.6932468.6432466.774
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue67,227.0064,926.0063,973.0059,871.0058,473.0048,907.0041,537.0046,586.0042,446.00
Cost of Goods Sold Incl. D&A19,217.0018,195.0016,802.0015,977.0017,206.0013,466.0013,443.0013,861.0013,065.00
Gross Profit48,010.0046,731.0047,171.0043,894.0041,267.0035,441.0028,094.0032,725.0029,381.00
Selling, General and Administrative Excl. Other35,627.0023,245.0026,527.0040,912.0021,766.0019,822.0018,034.0019,245.0019,697.00
Research and Development27,600.0012,514.0015,794.0030,530.0011,818.0010,207.009,126.008,664.009,598.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income12,383.0023,486.0020,644.002,982.0019,501.0015,619.0010,060.0013,480.009,684.00
Interest Expense1,961.001,357.001,271.001,146.00962.00806.00831.00893.00772.00
Unusual Expense7,111.001,704.001,179.001,029.502,269.003,159.005,038.002,494.00931.00
Net Income Before Taxes4,762.0021,067.0019,936.001,889.0016,444.0013,879.005,863.0011,464.008,701.00
Income Taxes2,313.002,804.002,803.001,512.001,918.001,521.001,340.001,687.002,508.00
Consolidated Net Income2,449.0018,263.0017,133.00377.0014,526.0012,358.004,523.009,777.006,193.00
Net Income From Continuing Operations2,453.0018,254.0017,117.00365.0014,519.0012,345.004,519.009,843.006,220.00
Net Income2,453.0018,254.0017,117.00365.0014,519.0013,049.007,067.009,843.006,220.00
EPS (Recurring)3.007.767.060.436.346.014.174.492.57
EPS (Basic, Before Extraordinaries)0.997.306.760.145.735.162.793.842.33
EPS (Diluted)0.987.286.740.145.715.142.783.822.32
EBITDA19,556.0029,324.0025,143.006,854.0023,410.0018,833.0013,546.0017,132.0014,203.00
Non-Operating Income (Expense)1,451.00642.001,742.001,082.50174.002,225.001,672.001,371.00720.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-695.00644.00549.00463.00410.00376.00360.00293.00
Price To Earnings Ratio151.19151.1920.8460.5618.4614.9028.0722.7631.40
Price To Sales Ratio5.364.063.954.644.823.985.005.044.82
Gross Margin71.4171.9873.7473.3170.5772.4767.6470.2569.22
Operating Margin18.4236.1732.274.9833.3531.9424.2228.9422.81
Net Margin3.6528.1226.760.6124.8326.6817.0121.1314.65
Shares Outstanding2,466.772,474.632,527.642,531.632,537.832,527.602,530.232,539.022,592.56
Market Capitalization364,980.26364,980.26251,648.59276,258.86281,302.63193,588.04197,338.31220,795.45189,460.84

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue18,123.0016,580.0016,200.0016,324.0017,183.0015,800.0015,619.0015,293.00
Cost of Goods Sold Incl. D&A5,137.004,724.004,539.004,817.004,194.003,847.003,885.003,528.00
Gross Profit12,986.0011,856.0011,661.0011,507.0012,989.0011,953.0011,734.0011,765.00
Selling, General and Administrative Excl. Other5,606.0011,043.0013,631.005,347.005,526.005,594.005,024.006,871.00
Research and Development3,895.009,229.0011,977.002,499.003,552.003,540.003,119.004,052.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income7,380.00813.00-1,970.006,160.007,463.006,359.006,710.004,894.00
Interest Expense546.00525.00479.00411.00327.00305.00313.00328.00
Unusual Expense1,536.001,576.001,432.002,567.00711.001,000.00631.001,195.00
Net Income Before Taxes5,559.00-683.00-3,534.003,420.006,745.004,999.005,903.004,170.00
Income Taxes492.00654.00709.00458.00958.00571.00818.00425.00
Consolidated Net Income5,067.00-1,337.00-4,243.002,962.005,787.004,428.005,085.003,745.00
Net Income From Continuing Operations5,065.00-1,335.00-4,240.002,963.005,785.004,427.005,079.003,743.00
Net Income5,065.00-1,335.00-4,240.002,963.005,785.004,427.005,079.003,743.00
EPS (Recurring)2.48-0.09-1.311.912.522.042.181.81
EPS (Basic, Before Extraordinaries)2.05-0.54-1.721.202.321.762.011.48
EPS (Diluted)2.04-0.54-1.721.192.321.762.011.48
EBITDA9,078.002,310.00-458.008,626.008,535.007,415.007,809.006,091.00
Non-Operating Income (Expense)261.00605.00347.00238.00320.00-55.00137.00799.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense---281.24164.3263.20140.62237.79
Price To Earnings Ratio151.1936.1616.5313.9212.9411.5213.3320.84
Price To Sales Ratio5.364.794.544.033.283.143.563.95
Gross Margin71.6571.5171.9870.4975.5975.6575.1376.93
Operating Margin40.724.90-12.1637.7443.4340.2542.9632.00
Net Margin27.95-8.05-26.1718.1533.6728.0232.5224.48
Shares Outstanding2,466.772,468.642,469.692,474.632,487.352,503.142,516.082,527.64
Market Capitalization364,980.26317,371.87297,403.79261,257.43209,638.68198,773.13226,737.35251,648.59

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments14,690.0013,765.007,161.0013,271.008,096.008,050.0010,450.008,864.008,498.00
Short Term Receivables12,679.0011,127.0011,072.0010,110.009,815.007,240.006,778.007,071.006,873.00
Inventories6,658.006,109.006,358.005,911.005,953.005,554.005,978.005,440.005,096.00
Other Current Assets9,489.007,781.007,577.006,430.006,402.006,920.004,277.004,500.004,299.00
Total Current Assets43,516.0038,782.0032,168.0035,722.0030,266.0027,764.0027,483.0025,875.0024,766.00
Net Property, Plant & Equipment26,823.0025,149.0024,488.0022,768.0020,865.0018,688.0016,126.0013,291.0012,439.00
Total Investments and Advances2,114.001,676.001,584.001,953.001,080.001,573.002,217.006,876.0012,163.00
Long-Term Note Receivable125.00-------0.00
Intangible Assets48,260.0038,038.0039,208.0041,473.0044,197.0032,983.0033,621.0029,684.0032,467.00
Deferred Tax Assets---0.000.000.00719.00656.00573.00
Other Assets16,028.0013,461.009,227.007,244.009,286.0010,580.004,231.006,255.005,464.00
Total Assets136,866.00117,106.00106,675.00109,160.00105,694.0091,588.0084,397.0082,637.0087,872.00
Short Term Debt Incl. Current Port. of LT Debt2,883.002,931.001,657.002,227.002,716.006,722.003,846.005,308.003,057.00
Accounts Payable4,404.004,079.003,922.004,264.004,609.004,327.003,738.003,318.003,102.00
Income Tax Payable4,726.003,914.002,649.001,986.001,224.001,597.00736.001,971.00708.00
Other Current Liabilities16,314.0017,496.0017,466.0015,762.0015,323.0014,681.0013,900.0011,609.0011,747.00
Total Current Liabilities28,327.0028,420.0025,694.0024,239.0023,872.0027,327.0022,220.0022,206.0018,614.00
Long Term Debt47,651.0035,339.0034,611.0029,758.0031,915.0026,695.0023,504.0019,806.0021,353.00
Provision for Risks Charges839.00939.001,231.001,223.001,871.003,613.003,379.002,710.002,701.00
Deferred Tax Liabilities1,439.001,387.00871.001,795.003,441.001,005.001,470.001,702.002,219.00
Other Liabilities5,948.004,649.006,633.006,087.006,338.007,544.007,823.009,331.008,416.00
Total Liabilities84,204.0070,734.0069,040.0063,102.0067,437.0066,184.0058,396.0055,755.0053,303.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity52,606.0046,313.0037,581.0045,991.0038,184.0025,317.0025,907.0026,701.0034,336.00
Total Shareholders Equity52,606.0046,313.0037,581.0045,991.0038,184.0025,317.0025,907.0026,701.0034,336.00
Accumulated Minority Interest56.0059.0054.0067.0073.0087.0094.00181.00233.00
Total Equity52,662.0046,372.0037,635.0046,058.0038,257.0025,404.0026,001.0026,882.0034,569.00
Total Liabilities & Stockholders Equity136,866.00117,106.00106,675.00109,160.00105,694.0091,588.0084,397.0082,637.0087,872.00
Book Value Per Share21.2618.3214.8418.1215.1110.0110.2010.3012.73
Tangible Book Value Per Share1.763.27-0.641.78-2.38-3.03-3.04-1.150.69
Full-Time Employees75,00075,00072,00069,00068,00074,00071,00069,00069,000
Price to Book Ratio8.135.666.706.325.077.808.507.073.82
Return on Assets14.3715.300.3413.5212.525.1411.797.302.61
Return on Equity36.9140.810.8734.5038.8817.6437.4220.386.43
Return on Invested Capital18.2120.960.5119.1718.6213.5919.9213.374.30
Quick Ratio1.301.151.001.231.020.810.970.921.06
Current Ratio1.541.361.251.471.271.021.241.171.33

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income2,449.0018,263.0017,133.00377.0014,526.0012,358.004,523.009,777.006,193.00
Depreciation7,344.005,838.004,499.003,872.003,909.003,214.003,486.003,652.004,519.00
Other Funds (Non Cash)14,644.001,018.004,752.0012,861.005,010.002,189.007,411.002,634.002,272.00
Funds from Operations22,141.0023,448.0025,135.0015,211.0021,877.0017,948.0014,854.0015,507.0012,475.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-3,438.00-6,976.00-3,667.00-2,205.00-2,782.00-3,839.00-4,601.00-2,067.00-1,553.00
Income Taxes Payable-137.001,023.00214.00380.00-540.00814.00-2,359.00827.00
Cash from Operating Activities18,703.0016,472.0021,468.0013,006.0019,095.0014,109.0010,253.0013,440.0010,922.00
Capital Expenditures-3,957.00-4,112.00-3,372.00-3,863.00-4,388.00-4,448.00-4,429.00-3,473.00-2,615.00
Net Assets From Acquisitions-25,293.00-10,042.00-4,093.00-12,032.00-121.00-12,907.00-6,606.00-4,954.00-431.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00--
Purchase or Sale of Investments1,232.00471.00-142.00703.00-483.001,025.002,717.005,420.007,258.00
Purchase of Investments-522.00-1,207.00-519.00-955.00-1,204.00-1.00-95.00-3,202.00-7,994.00
Sale Or Maturity of Investments1,754.001,678.00377.001,658.00721.001,026.002,812.008,622.0015,252.00
Other Uses-200.00-58.00-127.00-36.000.00-225.00-1,125.000.000.00
Other Sources-114.000.000.001,145.0032.000.000.00378.00102.00
Cash from Investing Activities-28,332.00-13,741.00-7,734.00-14,083.00-4,960.00-16,555.00-9,443.00-2,629.004,314.00
Cash Dividends Paid-8,366.00-8,176.00-7,840.00-7,445.00-7,012.00-6,610.00-6,215.00-5,695.00-5,172.00
Change in Capital Stock-3,042.00-4,992.00-1,129.00-1,221.00384.00-638.00-1,192.00-4,419.00-8,500.00
Repurchase of Common Pref Stock-3,536.00-5,084.00-1,306.00-1,346.000.00-840.00-1,281.00-4,780.00-9,091.00
Sale of Common Pref Stock494.0092.00177.00125.00384.00202.0089.00361.00591.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net12,664.0011,377.002,309.004,184.00-2,251.001,631.005,011.001,248.00837.00
Change in Long Term Debt12,727.0011,377.002,309.004,184.00-2,251.005,617.002,462.004,958.00-4,287.00
Issuance of Long Term Debt19,874.0013,880.003,599.005,939.000.007,936.004,419.004,958.000.00
Reduction of Long Term Debt-7,147.00-2,503.00-1,290.00-1,755.00-2,251.00-2,319.00-1,957.000.00-4,287.00
Net Financing Active Other Cash Flow-156.00-131.00-372.00-328.00-240.008,210.00-436.005.00-325.00
Other Financing Activities Uses-156.00-131.00-372.00-328.00-240.00-790.00-436.000.00-325.00
Cash from Financing Activities1,100.00-1,922.00-7,032.00-4,810.00-9,119.002,593.00-2,832.00-8,861.00-13,160.00
Exchange Rate Effect-79.00563.00-293.0023.00-410.00-133.00253.0017.00-205.00
Net Change in Cash-8,608.001,372.006,409.00-5,864.004,606.0014.00-1,769.001,967.001,871.00
Free Cash Flow14,746.0012,360.0018,096.009,143.0014,707.009,661.005,824.009,967.008,307.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow56.4463.0724.65163.5336.6563.75-54.9365.30
Deferred Taxes & Investment Tax Credit--1,671.00-1,249.00-1,899.00-1,568.00187.00-566.00-556.00-509.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments9,752.007,182.005,773.0014,690.0018,249.008,665.00
Short Term Receivables13,653.0013,428.0013,047.0012,679.0012,999.0012,716.00
Inventories6,164.006,207.006,479.006,658.006,444.006,601.00
Other Current Assets9,372.009,862.009,716.009,489.009,865.009,083.00
Total Current Assets38,941.0036,679.0035,015.0043,516.0047,557.0037,065.00
Net Property, Plant & Equipment25,904.0025,737.0025,433.0026,823.0025,639.0025,236.00
Total Investments and Advances2,684.002,397.002,530.002,114.002,294.001,970.00
Intangible Assets46,427.0046,560.0047,326.0048,260.0036,900.0036,784.00
Other Assets18,742.0018,304.0018,256.0016,028.0017,156.0016,468.00
Total Assets132,773.00129,802.00128,685.00136,866.00129,546.00117,523.00
Short Term Debt Incl. Current Port. of LT Debt4,088.002,825.002,444.002,883.001,405.001,434.00
Accounts Payable5,031.003,827.003,863.004,404.004,147.003,892.00
Income Tax Payable4,309.004,224.003,946.004,726.004,848.004,156.00
Other Current Liabilities15,373.0016,855.0016,692.0016,314.0018,228.0016,555.00
Total Current Liabilities28,801.0027,731.0026,945.0028,327.0028,628.0026,037.00
Long Term Debt49,689.0051,081.0046,673.0047,651.0039,969.0033,968.00
Provision for Risks Charges0.000.000.00839.000.000.00
Deferred Tax Liabilities1,460.001,433.001,494.001,439.001,381.001,427.00
Other Liabilities7,877.007,573.007,642.005,948.007,661.007,031.00
Total Liabilities87,827.0087,818.0082,754.0084,204.0077,639.0068,463.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity44,893.0041,933.0045,878.0052,606.0051,850.0048,993.00
Total Shareholders Equity44,893.0041,933.0045,878.0052,606.0051,850.0048,993.00
Accumulated Minority Interest53.0051.0053.0056.0057.0067.00
Total Equity44,946.0041,984.0045,931.0052,662.0051,907.0049,060.00
Total Liabilities & Stockholders Equity132,773.00129,802.00128,685.00136,866.00129,546.00117,523.00
Book Value Per Share18.2016.9918.5821.2620.8519.57
Tangible Book Value Per Share-0.62-1.87-0.591.766.014.88
Full-Time Employees---75,000--
Price to Book Ratio8.136.925.665.054.294.12
Return on Assets1.872.577.3314.3715.4114.26
Return on Equity5.076.9818.9736.9139.5135.44
Return on Invested Capital5.36-1.44-4.582.966.305.34
Quick Ratio1.141.101.061.301.441.17
Current Ratio1.351.321.301.541.661.42

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income5,067.00-1,337.00-4,243.002,962.005,787.004,429.00
Depreciation1,783.001,583.001,512.002,466.001,154.001,119.00
Other Funds (Non Cash)249.005,245.008,577.00573.00-221.00452.00
Funds from Operations6,487.004,947.005,531.005,176.006,508.005,552.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital71.00423.00-1,613.00-2,319.001,314.00-2,259.00
Cash from Operating Activities6,558.005,370.003,918.002,857.007,822.003,293.00
Capital Expenditures-1,040.00-893.00-991.00-1,033.00-987.00-764.00
Net Assets From Acquisitions-630.00-5,842.00-8,779.00-10,042.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments405.001,155.00-374.0046.00575.00-11.00
Purchase of Investments0.00-148.00-374.000.000.00-612.00
Sale Or Maturity of Investments405.001,303.000.0046.00575.00601.00
Other Uses-54.00-22.00-66.00-58.0015.005.00
Other Sources0.000.000.00-114.00114.000.00
Cash from Investing Activities-1,319.00-5,602.00-10,210.00-11,201.00-283.00-770.00
Cash Dividends Paid-2,099.00-2,144.00-2,105.00-2,018.00-2,031.00-2,077.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-406.00-714.00-717.00-1,205.00-1,309.00-1,333.00
Repurchase of Common Pref Stock-653.00-757.00-874.00-1,252.00-1,323.00-1,345.00
Sale of Common Pref Stock247.0043.00157.0047.0014.0012.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.004,890.00-79.007,853.005,976.0048.00
Change in Long Term Debt0.005,951.00-1,140.007,916.005,961.000.00
Issuance of Long Term Debt6,000.005,956.000.007,918.005,962.000.00
Reduction of Long Term Debt-6,000.00-5.00-1,140.00-2.00-1.000.00
Net Financing Active Other Cash Flow73.00-270.00-80.00121.002.00-194.00
Other Financing Activities Uses73.00-270.00-80.00121.002.00-194.00
Cash from Financing Activities-2,432.001,762.00-2,981.004,751.002,638.00-3,556.00
Exchange Rate Effect-46.00-37.00-19.0023.0010.00374.00
Net Change in Cash2,761.001,493.00-9,292.00-3,570.0010,187.00-659.00
Free Cash Flow5,518.004,477.002,927.001,824.006,835.002,529.00
Price to Free Cash Flow56.4440.8850.5462.5942.4429.73

Revenue breakdown

Adempas2024: 287.00M 2025: 312.00M
Alliance Revenue - Reblozyl2024: 371.00M 2025: 525.00M
Alliance revenue - Adempas/Verquvo2024: 415.00M 2025: 470.00M
Alliance revenue - Lynparza2024: 1.31B 2025: 1.45B
Belsomra2024: 222.00M 2025: 186.00M
Bridion2024: 1.76B 2025: 1.84B
Capvaxive2024: 97.00M 2025: 759.00M
Companion Animals2024: 2.42B 2025: 2.46B
Consolidation, Policy2024: 891.00M 2025: 515.00M
Delstrigo2024: 249.00M 2025: 306.00M
Dificid2024: 340.00M 2025: 247.00M
Gardasil/Gardasil 92024: 8.58B 2025: 5.23B
Isentress/Isentress HD2024: 394.00M 2025: 325.00M
Janumet2024: 935.00M 2025: 940.00M
Januvia2024: 1.33B 2025: 1.60B
Keytruda2024: 29.48B 2025: 31.64B
Keytruda Qlex2025: 40.00M
Lagevrio2024: 964.00M 2025: 380.00M
Lenvima2024: 1.01B 2025: 1.05B
Livestock2024: 3.46B 2025: 3.90B
Ohtuvayre2025: 178.00M
Other Pharmaceutical2024: 2.59B 2025: 2.92B
Pifeltro2024: 163.00M 2025: 171.00M
Pneumovax 232024: 263.00M 2025: 166.00M
Prevymis2024: 785.00M 2025: 978.00M
ProQuad MMR II Varivax2024: 2.49B 2025: 2.45B
Remicade2024: 114.00M
Rotateq2024: 711.00M 2025: 673.00M
Simponi2024: 543.00M
Vaxneuvance2024: 808.00M 2025: 825.00M
Welireg2024: 509.00M 2025: 716.00M
Winrevair2024: 419.00M 2025: 1.44B
Zerbaxa2024: 252.00M 2025: 312.00M
Asia Pacific2024: 3.06B 2025: 2.98B
China2024: 5.49B 2025: 1.94B
EMEA2024: 14.04B 2025: 14.58B
Japan2024: 3.28B 2025: 2.71B
Latin America2024: 3.46B 2025: 3.41B
Other Countries2024: 2.56B 2025: 2.88B
United States2024: 32.28B 2025: 36.51B
Animal Health segment2024: 5.88B 2025: 6.35B
Consolidation, Policy2024: 891.00M 2025: 515.00M
Pharmaceutical segment2024: 57.40B 2025: 58.14B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.08%26.6M2462.7M10.33M
2026-10-151.09%26.8M2464.6M9.90M
2026-09-301.15%28.3M2464.6M9.85M
2026-09-151.40%34.4M2464.6M10.21M
2026-08-311.23%30.3M2464.6M10.81M
2026-08-140.99%24.5M2464.6M10.20M
2026-07-311.15%28.3M2465.5M10.07M
2026-07-151.19%29.4M2465.4M10.37M
2026-06-301.27%31.4M2465.4M10.33M
2026-06-151.23%30.3M2463.7M9.93M
2026-05-291.24%30.5M2465.4M9.54M
2026-05-151.18%29.1M2465.4M9.59M
2026-04-301.06%26.2M2465.3M10.99M
2026-04-151.11%27.5M2467.9M11.30M
2026-03-311.12%27.7M2470.3M12.10M
2026-03-131.18%29.1M2470.3M12.73M
2026-02-271.26%31.1M2470.3M13.32M
2026-02-131.14%28.1M2470.3M14.65M
2026-01-301.16%28.7M2478.8M13.95M
2026-01-151.36%33.7M2479.4M13.56M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call80.0065.0567.500.005.1470.000.000.997-0.0730.001
call85.0060.0562.500.004.7020.000.000.997-0.0730.001
call90.0054.8057.500.004.2810.000.000.996-0.0730.001
call95.0049.9052.500.003.8800.000.000.996-0.0720.001
call10044.9547.550.003.5410.000.000.996-0.0720.001
call10539.9042.550.003.1690.000.000.995-0.0710.001
call11034.8037.550.002.8110.000.000.994-0.0700.002
call11529.8032.550.002.4620.000.000.994-0.0690.002
call12024.8527.450.002.0620.000.000.993-0.0670.002
call12421.5023.2022.191.6441.001.000.991-0.0660.002
call12520.5521.9521.261.39712.003.000.991-0.0660.003
call12619.3021.2520.271.6362.003.000.991-0.0650.003
call12717.9520.3019.431.5201.002.000.990-0.0650.003
call12817.3018.5517.991.3392.002.000.990-0.0640.003
call12916.3017.6517.060.8252.001.000.989-0.0640.003
call13014.9517.5517.311.52318.000.000.989-0.0630.003
call13113.8016.5515.971.39010.000.000.988-0.0630.003
call13212.8015.5516.671.32411.000.000.987-0.0630.003
call13311.9014.5513.941.32913.000.000.982-0.0790.005
call13410.8013.5513.491.18985.000.000.976-0.1040.006
call1359.8012.6012.651.25237.000.000.960-0.1540.009
call1369.3010.759.780.80482.002.000.953-0.1710.010
call1378.309.808.800.77077.002.000.944-0.1880.012
call1387.108.807.500.57397.004.000.942-0.1750.012
call1396.207.707.030.44551.0010.000.939-0.1640.013
call1405.557.056.250.5893378.000.890-0.2740.020
call1414.555.755.320.38826410.000.889-0.2360.020
call1423.604.904.050.42077.0010.000.850-0.2760.025
call1433.003.904.740.34333.000.000.810-0.2990.029
call1442.833.152.800.34048.001.000.730-0.3770.035
call1452.092.382.160.3391454.000.657-0.3930.039
call1461.471.841.400.36670.003.000.558-0.4260.042
call1470.961.191.060.32219123.000.466-0.4120.043
call1480.630.890.650.35130239.000.366-0.3950.040
call1490.400.500.460.3241591390.272-0.3350.035
call1500.220.300.260.3231,0332200.227-0.3470.032
call152.50.030.080.050.33344591.000.155-0.3430.026
call1550.010.020.020.3743636.000.048-0.1330.011
call157.50.000.010.040.4411,9511.000.033-0.1090.008
call1600.000.060.010.4774111.000.011-0.0400.003
call162.50.000.950.100.54927.000.000.005-0.0230.002
call1650.000.270.010.6221381.000.005-0.0240.002
call167.50.000.020.010.7554352.000.008-0.0440.002
call1700.000.020.010.7616.004.000.004-0.0250.001
call172.50.000.020.010.90035.002.000.007-0.0450.002
call1750.000.250.010.89025.0011.000.003-0.0260.001
call1800.000.020.01-40.000.00---
call1850.000.020.021.23029.0021.000.005-0.0480.002
call1900.000.020.011.2521999.000.003-0.0270.001
call1950.002.130.041.36217.0015.000.002-0.0280.001
call2000.000.020.011.4681325.000.002-0.0280.001
call2050.000.020.01-83.000.00---
call2100.002.130.001.7900.000.000.004-0.0520.001
call2150.002.130.001.8920.000.000.003-0.0520.001
put80.000.002.130.013.0851.000.00-0.003-0.0730.001
put85.000.002.130.002.7960.000.00-0.003-0.0720.001
put90.000.002.130.012.5233.000.00-0.003-0.0710.001
put95.000.002.130.002.2630.000.00-0.004-0.0700.001
put1000.002.130.002.0160.000.00-0.004-0.0690.001
put1050.002.130.001.7780.000.00-0.005-0.0670.001
put1100.000.070.071.60321.000.00-0.008-0.0950.002
put1150.002.130.061.3407.000.00-0.006-0.0650.002
put1200.002.130.181.1421040.00-0.007-0.0630.002
put1240.001.150.000.9740.000.00-0.008-0.0620.002
put1250.001.240.190.93316.000.00-0.009-0.0610.003
put1260.000.750.000.8910.000.00-0.009-0.0600.003
put1270.000.750.000.8500.000.00-0.010-0.0600.003
put1280.000.750.010.8099.001.00-0.010-0.0590.003
put1290.000.040.020.7673.0010.00-0.011-0.0590.003
put1300.000.040.010.7261981.00-0.011-0.0580.003
put1310.000.040.020.68516.002.00-0.012-0.0570.003
put1320.000.080.040.64665.000.00-0.012-0.0570.003
put1330.000.030.020.60466.007.00-0.016-0.0700.004
put1340.000.040.030.58714.002.00-0.025-0.1000.006
put1350.010.050.030.5643893.00-0.035-0.1320.008
put1360.010.100.050.5881912.00-0.047-0.1650.010
put1370.020.110.090.5501372.00-0.056-0.1820.012
put1380.040.130.200.5222460.00-0.058-0.1690.012
put1390.030.150.150.48573.0027.00-0.065-0.1690.014
put1400.070.250.150.49321230.00-0.113-0.2750.020
put1410.040.310.200.4651351.00-0.115-0.2380.021
put1420.170.360.370.4256768.00-0.150-0.2700.025
put1430.380.530.530.4221509.00-0.195-0.2990.029
put1440.590.760.780.4163746.00-0.267-0.3550.035
put1450.871.071.110.41245823.00-0.346-0.3860.039
put1461.241.491.850.4123954.00-0.441-0.4190.042
put1471.712.002.200.42992.0032.00-0.534-0.4050.043
put1482.302.592.850.4203381.00-0.629-0.3900.040
put1492.983.303.660.42318.002.00-0.728-0.3280.035
put1503.754.554.340.57780.006.00-0.768-0.3450.033
put152.55.257.806.130.9672070.00-0.845-0.3360.026
put1557.5010.358.501.15920.000.00-0.925-0.1960.015
put157.510.0012.7511.051.29415.000.00-0.971-0.0860.007
put16012.5015.300.001.4640.000.00-0.989-0.0320.003
put162.515.0018.3016.251.7680.000.00-0.994-0.0150.002
put16517.5020.500.001.7320.000.00-0.991-0.0340.002
put167.520.0023.050.001.9710.000.00-0.995-0.0150.001
put17022.5025.500.002.0850.000.00-0.996-0.0150.001
put172.525.0028.1025.982.2471.0016.00-0.996-0.0150.001
put17527.5030.7528.462.4251.0016.00-0.996-0.0160.001
put18032.5035.6034.322.6060.000.00-0.997-0.0160.001
put18537.5040.600.002.8290.000.00-0.997-0.0160.001
put19042.5045.500.002.9990.000.00-0.997-0.0160.001
put19547.5050.400.003.1550.000.00-0.997-0.0150.001
put20052.5055.600.003.4340.000.00-0.998-0.0150.001
put20557.5060.650.003.5120.000.00-0.996-0.0380.001
put21062.5065.300.003.6540.000.00-0.998-0.0150.001
put21567.5070.350.003.8450.000.00-0.998-0.0150.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-11-033Initial statement of beneficial ownership of securities2026-11-01SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-223/A2026-05-01SEC
2026-10-1525-NSESEC
2026-10-138-KCurrent report2026-10-09SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-013Initial statement of beneficial ownership of securities2026-09-01SEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-0713F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-06-30SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080029.98M9
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020040.70M12
2026-010000
2025-120000
2025-11001.34M2

Institutional holders

Manager% owned
BlackRock, Inc.9.19%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
WELLINGTON MANAGEMENT GROUP LLP3.49%
VANGUARD PORTFOLIO MANAGEMENT LLC2.74%
GEODE CAPITAL MANAGEMENT, LLC2.50%
TPG GP A, LLC2.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2.20%
MORGAN STANLEY1.97%
FMR LLC1.87%
JPMORGAN CHASE & CO1.78%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND2.25%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND2.02%
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND1.88%
Schwab U.S. Dividend Equity ETF1.47%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.30%
VANGUARD INSTITUTIONAL INTERMEDIATE-TERM BOND FUND1.21%
SPDR S&P 500 ETF TRUST1.21%

OakChart. MRK. Cached 15 minutes.